Dr. de la Rocha receives 2 million euros from the ERC for the study of neural mechanisms
Dr. Jaime de la Rocha, head of Cortical Circuit Dynamics research group at IDIBAPS, will receive €2 million over the next five years to strengthen...
Dr. Jaime de la Rocha, head of Cortical Circuit Dynamics research group at IDIBAPS, will receive €2 million over the next five years to strengthen...
IDIBAPS takes part in the European HIV Vaccine Alliance (EHVA) to develop and evaluate new preventive and therapeutic vaccines. The European Commi...
Researchers from Hospital Clínic, IDIBAPS, University of Barcelona (UB) and Mental Health Research Center (CIBERSAM), associated with Institute o...
IDIBAPS and Fundació Clínic take part in two of the ERIC (European Research Infrastructure Consortium) consortiums promoted by the European Commiss...
Researchers from the IIBB-CSIC and IDIBAPS have published an article in Oncotarget journal in which they have shown for the first time that diets...
Dr. Jordi Bruix, Head of the hepatic Oncology Unit at Hospital Clínic de Barcelona, the Hepatic Oncology IDIBAPS research team, the Barcelona Clin...
Researchers at Hospital Clínic and IDIBAPS lead a study in which a genomic test performed at the time of diagnosis in breast cancer is useful to id...
Aelix Therapeutics, a drug development company created from the HIVACAT project and specialized in the discovery and development of immunotherapies...
The CIBERER (Networked Biomedical Research Center for Rare Diseases) has incorporated two new research groups, among them the Pathogenesis of auto...
IDIBAPS researchers in collaboration with CIBERNED scientists identify for the first time, in a study published in EMBO Molecular Medicine, numero...